Company news
Solvonis Therapeutics Plc (LSE:SVNS) news
Solvonis Therapeutics Plc news releases on 6ix. Latest, Apr 27, 2023: Final Results
Press releases — page 3
Final Results
April 27, 2023
GraftBio - MGC Pharma Update
March 21, 2023
Corporate Presentation
March 20, 2023
Update: New Product Lines & Facility Expansion
February 9, 2023
Interim Results
September 30, 2022
New Corporate Presentation
September 20, 2022
First Commercial Purchase Order for GraftBio
August 18, 2022
GraftBio IP - MGC Pharma Update
June 17, 2022
HACCP Certificate Enabling Access to B2C Market
May 12, 2022
Grant of patents
April 22, 2022
Pre-payment for equipment
April 7, 2022
Director/PDMR Shareholding
April 6, 2022
Update on Operations
February 21, 2022
Change of Year End
February 15, 2022
Admission to Main Market, First Day of Dealings
January 6, 2022